Biointerface quantum and nanosensing tools to study autophagy in cancer
Official title: Biointerface quantum and nanosensing technologies to investigate autophagic pathways
Funded at Georgia Institute of Technology · NIH-11429059 · Data updated 2026-11-12
A new funding opportunity uses advanced quantum and nanosensing tech, along with AI, to better understand how autophagy and lysosome function affect cancer cells.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Georgia Institute of Technology NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project start | August 1, 2026 |
| Project end | July 31, 2031 |
| Funding year | 2026 |
| Award (this year) | $421,857 |
| NIH project number | 1R35GM166288-01 |
| Project ID | NIH-11429059 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates are people whose cancers involve autophagy dysregulation and who might participate in future translational studies or biomarker development.
✕Less likely to help
People with cancers not driven by autophagy or lysosomal dysfunction may see limited direct benefit.
What this research studies
This grant funds research at Georgia Tech to develop and apply ultra-sensitive sensing methods that monitor autophagy and lysosomal activity in living cells. The team will use quantum and nano-scale sensors plus artificial intelligence to capture real-time changes in cellular processes linked to cancer, aiming to reveal how autophagy influences tumor behavior. By tracking lysosomal pH and related signals, the project seeks to connect molecular events to potential new therapeutic strategies for cancer.
Why it matters
Potential benefit: If successful, patients could benefit from breakthroughs in cancer therapies that target autophagy and lysosome pathways.
How similar studies have gone: Previous work shows that advanced sensing and AI can reveal dynamic cellular processes, but integrating quantum/nano sensing for autophagy in living systems is still emerging.
Where this research is happening
-
Georgia Institute of Technology
Atlanta, United States Active
Researchers
- Principal investigator: Kim, Mijin — Georgia Institute of Technology
- Study coordinator: Kim, Mijin
Related research
Other NIH-funded projects on the same topics.
-
Integrative AI tools to map protein sequences to structures and functions
A scientist team will develop advanced AI methods to better connect protein sequences, their 3D shapes, and how they work, using large biological data from sequencing and structures.
-
Robotic ultrasound-guided clot removal for stroke treatment
A new robot-assisted ultrasound system is being developed to help quickly reopen brain arteries during a stroke, with testing in patient-specific 3D-printed models and animal studies.
-
siRNA nanoparticle treatment to stop diabetic kidney damage
A new nanoparticle-delivered gene-silencing treatment aims to lower kidney inflammation in people with diabetes to help protect their kidneys.
-
Nanosensor blood test to spot early pancreatic cancer fingerprints
This project will use a nanosensor blood test to detect early-stage pancreatic cancer by reading a disease 'fingerprint' in patient serum.
-
Synergistic blood-brain barrier opening and targeted glioma treatment with pulsed electric fields
A new approach uses tiny, rapid electric pulses to safely disrupt the brain's protective barrier and enhance targeted treatment for malignant glioma.
-
Dexterous needle ablation for ventricular arrhythmia guided by MRI
A new MRI-guided, robot-assisted catheter delivers deeper heart tissue ablation to treat ventricular tachycardia.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.